Brookstone Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Brookstone Capital Management's HALO Position: Q3 2026 in Review
Brookstone Capital Management reduced its Halozyme (HALO) stake by 33% in Q3 2026, selling an estimated $350K and leaving 7,408 shares worth $818K. The position accounts for 0.01% of the portfolio, ranked #769.
Brookstone Capital Management first reported a position in HALO in Q2 2021 and has held it in 18 quarters since. The position peaked at $3.93M in Q1 2025. 774 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Brookstone Capital Management held 7,408 shares of Halozyme worth $818K as of Q3 2026.
- Brookstone Capital Management sold 3,624 Halozyme shares in Q3 2026, an estimated $350K.
- Halozyme made up 0.01% of Brookstone Capital Management's portfolio in Q3 2026, its #769 holding.
- Brookstone Capital Management first reported a position in Halozyme in Q2 2021 and has held it in 18 quarters since.
- Brookstone Capital Management's Halozyme position peaked at $3.93M in Q1 2025.
- 774 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Brookstone Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.